glp-1 and cancer risk GLP-1s tied to lower for 10 types of compared with insulin in type 2 diabetes New study examines GLP-1 drugs

These drugs also appear to reduce microglial activation (neuroinflammation) and enhance neuroplasticity

When you hear the words carpal tunnel syndrome, your mind might immediately jump to wrist pain

Non-GLP-1 options For people who cannot tolerate GLP-1 medications or prefer a different approach, other evidence-based options exist

The average time from symptom onset to definitive diagnosis ranges from 7 to 12 years across different healthcare systems, a delay that would be considered unacceptable for most other chronic conditions (Surrey et al., 2020)

Formulated with Adenosine, it also offers an anti-wrinkle benefit

For a patient with a personal history of papillary thyroid cancer who is struggling with obesity-related comorbidities, how do you weigh the metabolic benefits of a GLP-1 against the theoretical oncological concerns